SRD5A3 and metabolic dysfunction-associated steatohepatitis: Compared with the NC group, the expression levels of lncRNAs SRD5A3-AS1 (F value: 304.1, p value < 0.001) and RPARP-AS1(F value: 59.51, p value < 0.001) were significantly decreased in both the NASH and SS groups (Figure 4C).